MESO
Price
$14.38
Change
+$0.86 (+6.36%)
Updated
Sep 5, 11:22 AM (EDT)
Capitalization
1.66B
82 days until earnings call
QSI
Price
$1.07
Change
-$0.00 (-0.00%)
Updated
Sep 4 closing price
Capitalization
216.67M
61 days until earnings call
Interact to see
Advertisement

MESO vs QSI

Header iconMESO vs QSI Comparison
Open Charts MESO vs QSIBanner chart's image
Mesoblast
Price$14.38
Change+$0.86 (+6.36%)
Volume$200
Capitalization1.66B
Quantum-Si
Price$1.07
Change-$0.00 (-0.00%)
Volume$3.7M
Capitalization216.67M
MESO vs QSI Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. QSI commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Hold and QSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (MESO: $13.52 vs. QSI: $1.07)
Brand notoriety: MESO and QSI are both not notable
MESO represents the Biotechnology, while QSI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: MESO: 129% vs. QSI: 52%
Market capitalization -- MESO: $1.66B vs. QSI: $216.67M
MESO [@Biotechnology] is valued at $1.66B. QSI’s [@Medical/Nursing Services] market capitalization is $216.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, QSI is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 6 TA indicator(s) are bullish while QSI’s TA Score has 5 bullish TA indicator(s).

  • MESO’s TA Score: 6 bullish, 4 bearish.
  • QSI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MESO is a better buy in the short-term than QSI.

Price Growth

MESO (@Biotechnology) experienced а -15.24% price change this week, while QSI (@Medical/Nursing Services) price change was -6.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +8.36%, and the average quarterly price growth was +29.87%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.38%. For the same industry, the average monthly price growth was +2.60%, and the average quarterly price growth was +24.44%.

Reported Earning Dates

MESO is expected to report earnings on Nov 26, 2025.

QSI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (-0.38% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.66B) has a higher market cap than QSI($217M). MESO YTD gains are higher at: -31.717 vs. QSI (-60.370). MESO has higher annual earnings (EBITDA): -77.78M vs. QSI (-106.38M). QSI has more cash in the bank: 214M vs. MESO (37.7M). QSI has less debt than MESO: QSI (11.1M) vs MESO (126M). MESO has higher revenues than QSI: MESO (5.67M) vs QSI (3.41M).
MESOQSIMESO / QSI
Capitalization1.66B217M766%
EBITDA-77.78M-106.38M73%
Gain YTD-31.717-60.37053%
P/E RatioN/AN/A-
Revenue5.67M3.41M166%
Total Cash37.7M214M18%
Total Debt126M11.1M1,135%
FUNDAMENTALS RATINGS
MESO: Fundamental Ratings
MESO
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MESOQSI
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIICX10.52N/A
N/A
BlackRock Multi-Asset Income Instl
STCAX17.27N/A
N/A
Virtus Silvant Large-Cap Growth Stk I
LSSIX29.42N/A
N/A
Loomis Sayles Small Cap Growth Instl
STPCX12.66N/A
N/A
Saratoga Technology & Comm C
REGRX19.35-0.01
-0.05%
Russell Inv Emerging Markets R6